What is it about?
This complements our initial work on development of radiolabeled derivatives of the cyclin-dependent kinase 4/6 inhibitor palbociclib (PD 0332991) for functional imaging of this key enzyme in various cancers.
Featured Image
Read the Original
This page is a summary of: Cell Cycle Regulating Kinase Cdk4 as a Potential Target for Tumor Cell Treatment and Tumor Imaging, Journal of Oncology, January 2009, Hindawi Publishing Corporation,
DOI: 10.1155/2009/106378.
You can read the full text:
Contributors
The following have contributed to this page
